Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.Business Wire • 02/27/24
Sorrento Therapeutics, Inc. Announces Auction for Sale of Scilex Securities and Bankruptcy Court Approval of Stalking Horse BidPRNewsWire • 08/08/23
Gold Hunter Resources Completes the Sale of Certain Properties to Sorrento ResourcesNewsfile Corp • 06/14/23
Gold Hunter Resources Inc. Sells a Portion of Its Newfoundland Projects to Sorrento ResourcesNewsfile Corp • 06/06/23
Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the ASCO 2023 MeetingGlobeNewsWire • 06/05/23
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 CasePRNewsWire • 02/21/23
Sorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)GlobeNewsWire • 02/19/23
Sorrento Issues Update to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)GlobeNewsWire • 02/17/23
Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management MotionsPRNewsWire • 02/16/23
Sorrento Therapeutics (SRNE) Loses -77.24% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 02/14/23
Joint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today's Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.GlobeNewsWire • 02/13/23
Sorrento Therapeutics stock plummets more than 60% on news of bankruptcy filingProactive Investors • 02/13/23
A biotech company that once claimed to have a 'cure' for COVID-19 just filed for bankruptcy, sending shares plunging 59%Business Insider • 02/13/23